BR9808482A - Método de titragem de uma composição viral complexa - Google Patents

Método de titragem de uma composição viral complexa

Info

Publication number
BR9808482A
BR9808482A BR9808482-8A BR9808482A BR9808482A BR 9808482 A BR9808482 A BR 9808482A BR 9808482 A BR9808482 A BR 9808482A BR 9808482 A BR9808482 A BR 9808482A
Authority
BR
Brazil
Prior art keywords
viruses
species
type
viral composition
complex viral
Prior art date
Application number
BR9808482-8A
Other languages
English (en)
Inventor
Catherine Gerdil
Jean-Francois Saluzzo
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of BR9808482A publication Critical patent/BR9808482A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

<B>MéTODO DE TITRAGEM DE UMA COMPOSIçãO VIRAL COMPLEXA<D> A invenção tem como objetivo um método para determinar, em uma composição contendo diferenrtes espécies ou tipos de vírus vivos, a quantidade de vírus de cada um dos tipos ou espécies de vírus, compreendendo as etapas seguintes: propagação de vírus de cada tipo ou espécie em células permissivas aos vírus mas não induzindo interferência viral, dosagem de cada tipo ou espécie de vírus em um meio de um anti-corpo monoclonal específico.
BR9808482-8A 1997-04-04 1998-04-03 Método de titragem de uma composição viral complexa BR9808482A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704371A FR2761698B1 (fr) 1997-04-04 1997-04-04 Methode de titrage d'une composition virale complexe
PCT/FR1998/000678 WO1998045709A1 (fr) 1997-04-04 1998-04-03 Methode de titrage d'une composition virale complexe

Publications (1)

Publication Number Publication Date
BR9808482A true BR9808482A (pt) 2001-07-31

Family

ID=9505710

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808482-8A BR9808482A (pt) 1997-04-04 1998-04-03 Método de titragem de uma composição viral complexa

Country Status (15)

Country Link
US (1) US6890711B1 (pt)
EP (1) EP0974055B1 (pt)
KR (1) KR100543344B1 (pt)
CN (1) CN1130465C (pt)
AT (1) ATE235685T1 (pt)
AU (1) AU737465B2 (pt)
BR (1) BR9808482A (pt)
CA (1) CA2285647C (pt)
DE (1) DE69812601T2 (pt)
DK (1) DK0974055T3 (pt)
ES (1) ES2191299T3 (pt)
FR (1) FR2761698B1 (pt)
NZ (1) NZ500005A (pt)
PT (1) PT974055E (pt)
WO (1) WO1998045709A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159969A1 (fr) * 2000-05-30 2001-12-05 Aventis Pasteur Vaccine composition
US8589667B2 (en) 2010-04-19 2013-11-19 Apple Inc. Booting and configuring a subsystem securely from non-local storage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511702B1 (fr) * 1981-08-24 1985-09-13 Pasteur Institut Anticorps monoclonaux antipoliovirus pour l'identification du type et la differenciation intratypique de souches isolees de poliovirus, hybrides cellulaires pour leur fabrication et procede de diagnostic in vitro mettant en jeu des anticorps
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
FR2694022B1 (fr) * 1992-07-21 1994-09-30 Int Mycoplasma Procédé d'amplification des agents infectieux en diagnostic "in vitro" sur cultures cellulaires.
JPH06222062A (ja) * 1993-01-22 1994-08-12 Teijin Ltd ウイルス感染価および中和抗体価の測定法

Also Published As

Publication number Publication date
NZ500005A (en) 2001-07-27
EP0974055A1 (fr) 2000-01-26
KR20010006045A (ko) 2001-01-15
AU7055298A (en) 1998-10-30
DK0974055T3 (da) 2003-07-21
PT974055E (pt) 2003-08-29
FR2761698B1 (fr) 1999-05-07
DE69812601D1 (de) 2003-04-30
DE69812601T2 (de) 2003-10-09
CN1259207A (zh) 2000-07-05
AU737465B2 (en) 2001-08-23
CN1130465C (zh) 2003-12-10
FR2761698A1 (fr) 1998-10-09
EP0974055B1 (fr) 2003-03-26
ES2191299T3 (es) 2003-09-01
CA2285647C (fr) 2008-11-18
CA2285647A1 (fr) 1998-10-15
ATE235685T1 (de) 2003-04-15
US6890711B1 (en) 2005-05-10
WO1998045709A1 (fr) 1998-10-15
KR100543344B1 (ko) 2006-01-20

Similar Documents

Publication Publication Date Title
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
AUPO351996A0 (en) Viral variants and methods for detecting same
IT8249401A0 (it) Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici
DK143181A (da) Apparat til indgivelse af en bedoevende gas
DE69942054D1 (de) System zur kontrollierten Annahme von Poststücken mit Betrugserfassung
NO163463C (no) Apparat for bruk ved broenn-testing.
DE3177290D1 (de) Monoklonale antikoerper gegen hepatitis-b-virus.
ES2070820T3 (es) Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
ATE221657T1 (de) Entstörung durch rheumafaktoren
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
BR9808482A (pt) Método de titragem de uma composição viral complexa
DK0740789T3 (da) Fremgangsmåde til at teste for mastitis i pattedyr samt system til udøvelse af fremgangsmåden
NO851518L (no) Monoklonale antistoffer eller fragmenter derav, spesifikke for alfa2-plasmininhibitor
DE69738503D1 (de) Den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte
CA2419046A1 (en) Method for detecting or measuring hbv
IS5620A (is) Greiningar aðferðir
ES522186A0 (es) Metodo de ensayo de anticuerpos.
ES2132115T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.
DE59007799D1 (de) Getterzusammensetzung für Lichtquellen.
DE69826029D1 (de) Acetyl-coa-carboxylase von candida albicans
ITRM930038A0 (it) Corredo per analisi microbiologiche mediante coltura.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA (ART. 8O COMBINADO COM ART. 13 DA LPI 9279/96).

B12B Appeal against refusal [chapter 12.2 patent gazette]